Vontobel

                   
wsj.com: [Viehbacher, Chris] wsj.com

Sanofi CEO Expected to Map Fresh Course

wsj.com
yesterday 4 related
        

LONDON -- Christopher Viehbacher is likely to have big changes in store for French drug maker Sanofi-Aventis SA when he takes over as chief executive this week. Paris-based Sanofi is one of the world's largest drug makers by...

add comment
                   

EU issues preliminary report on the competition inquiry into the pharmaceutical industry

pharmiweb.co.uk
Nov 29, 2008 3 related
        

by Nadege Chery The European Commission published its preliminary report on the competition inquiry into the pharmaceutical industry, which found that competition in this sector "does not work as well as it should." Competition...

add comment

Swiss life to cut 200 jobs, market worries remain

marketwatch.com
Nov 26, 2008 6 related
        

By Martin Gelnar Of DOW JONES NEWSWIRES ZURICH (Dow Jones)--Swiss Life Holding AG Wednesday said it would cut 200 jobs in Switzerland as part of a cost-savings plan, but saw its shares fall as analysts said the company still...

add comment
                   

Tepid jewelry auctions show wealthy holding back

reuters.com
Nov 21, 2008 5 related
        

GENEVA/ZURICH (Reuters Life!) - The world's wealthiest people were bidding timidly at Christie's and Sotheby's jewelry sales this week, in a sign the financial crisis has caused even the super-rich to hold back.

add comment
                   

Xetra-Gold enters Luxembourg

finextra.com
Nov 20, 2008 1 related
        

Xetra-Gold (ISIN: DE000A0S9GB0), the first financial product combining the benefits of physical gold with exchange-traded securities is being launched to investors on the Luxembourg market by Deutsche Börse Commodities after...

add comment

UPDATE 3-Carrefour picks Nestle marketing chief as new CEO

finanznachrichten.de
Nov 18, 2008 44 related
        

By James Regan and Emma Thomasson PARIS/ZURICH, Nov 18 (Reuters) - French food retailer Carrefour poached Swiss Nestle's marketing head to lead the company and shake up its key domestic hypermarket business, dropping its...

add comment
                   

Swissmedic gives thumbs-up to Basilea/J&J's Zevtera

pharmiweb.co.uk
Nov 14, 2008 17 related
        

Switzerland’s Basilea Pharmaceutica has been boosted by the news that local regulators have backed the firm's superbug antibiotic ceftobiprole. Basilea and partner Johnson & Johnson say that Swissmedic has granted approval for...

add comment
                   

CORRECTED - UPDATE - Basilea gets Swiss approval for superbug drug (at Reuters)

yahoo.com
Nov 13, 2008 2 related
        

By Sam Cage ZURICH, Nov 13 (Reuters) - Basilea Pharmaceutica's (BSLN.S: ) MRSA drug ceftobiprole has received approval in Switzerland, the Swiss biotech company said on Thursday. Regulator Swissmedic has approved the drug --...

add comment
                   

UBS shares drop after U.S. indicts top banker

reuters.com
Nov 13, 2008 139 related
        

ZURICH (Reuters) - Shares in UBS fell Thursday after U.S. authorities charged the Swiss bank's wealth management boss with helping Americans hide $20 billion from the taxman, putting Swiss bank secrecy laws in the spotlight again.

add comment
                   
swissinfo.ch: An engineer from Rieter checks the company's acoustic components swissinfo.ch

Car component makers face uncertain future

swissinfo.ch
Nov 11, 2008
        

An engineer from Rieter checks the company's acoustic components (Keystone) The financial crisis has hit the worldwide motor industry. The total turnover of component suppliers in Switzerland is SFr16 billion ($14 billion), and...

add comment
1 2 next